Peter J. Dailey PhD, MPH

Assistant Adjunct Professor, Infectious Diseases and Vaccinology
  • PH 266B Zoonotic Diseases
Research Interests: 
  • Development, evaluation, and implementation of assays for the estimation of HIV incidence
  • Development, evaluation, and enabling access of infectious disease diagnostics in low-resource settings
Current Projects: 
  • Senior Technical Officer for the Foundation for Innovative New Diagnostics (FIND). FIND is a nonprofit organization headquartered in Geneva, Switzerland whose mission is to drive the development and early implementation of innovative diagnostic tests that have a high impact on patient care, disease control, and public health in low-resource settings.
  • “HIV Incidence Assay Development Partner,” grant funded through FIND. Coordination of multiple projects related to the development, evaluation, and implementation of HIV Incidence Assays. FIND: Measuring HIV Incidence 
  • “PanDx: A Low-cost Diagnostics Platform for Health Centers in the Developing World”: discover and develop a prototype affordable, easy-to-use system for health workers to rapidly diagnose diseases in resource-limited settings. Prototype assays for tuberculosis (nucleic acid assay) and HIV (immunoassay) will be developed. This project is part of the Grand Challenges in Global Health Diagnostics initiative funded by the Bill & Melinda Gates Foundation to Stratos Product Development.
Selected Publications: 

Holger Becker, Richard Klemm, William Dietze, Wallace White, Nadine Hlawatsch, Susanne Freyberg, Christian Moche, Peter Dailey, and Claudia Gärtner.  Modular microfluidic cartridge-based universal diagnostic system for global health applications.  2016. Proc. SPIE 9705, Microfluidics, BioMEMS, and Medical Microsystems XIV, 970514 (March 18, 2016)

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.  2010. J Clin Microbiol. 48(1):229-37.

Patel SR, Weir F, Dailey P, Persing DH.  Democratizing molecular diagnostics: the GeneXpert enterovirus assay.  2009. Expert Opin. Med. Diagn. 3(1): 91-7.

Nolte, F.S., Arbique, J.C., Cockerill, F.R., Dailey, P.J., Hillyard, D., McDonough, S., Meyer, R.F., and Shively, R.G.  Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline—Second Edition (MM3-A2), 2005. Clinical Laboratory Standards Institute 26 (8).

Van Rompay, K.K.A., P. J. Dailey, D. R. Canfield, R. P. Tarara, N. L. Aguirre, N. Bischofberger, N. C. Pedersen, and M. L. Marthas.  Early short-term 9-[2-(Phosphonomethoxy)-propyl]adenine (PMPA) treatment reduces viremia, enhances immune responses, and prolongs survival for simian immunodeficiency virus-infected newborn rhesus macaques.  1999.  J. Virology 73: 2947-2955.

Baba, T.W., V. Liska, A. H. Khimani, N.B. Ray, P.J. Dailey, D. Penninck, R. Bronson, M.F. Greene, H.M. McClure, L.N. Martin, and R.M. Ruprecht.  Live-attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.  1999. Nature Medicine 5:194-203.

Connor, R. I., D. C. Montefiori, J. M. Binley, J. P. Moore, S. Bonhoeffer, A. Gettie, K. E. Sheridan, D. D. Ho, P. J. Dailey, and P. A. Marx.  Temporal analyses of virus replication, immune responses and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.  1998.  J. Virology 72: 7501-7509. 

Harris, M., P. Patenaude, P. Cooperberg, D. Filipenko, A. Thorne, J. Raboud, S. Rae, P. Dailey, D. Chernoff, J. Todd, B. Conway, J. S. G. Montaner, and the INCAS Study Group.  1997.  Correlation of viral load in plasma and lymph node tissue in HIV infection. J. Infec. Dis. 176: 1388-92.

Terrault, N. A., P. J. Dailey, L. Ferrell, M. L. Collins, J. C. Wilber, M. S. Urdea, B. N. Bhandari, and T. L. Wright.  1997.  Hepatitis C Virus: Quantitation and Distribution in Liver. J. Med. Virol.  51: 217-224.

Marx, P. A., A. I. Spira, A. Gettie, P. J. Dailey, R. S. Veazey, A. A. Lackner, C. James Mahoney, C. J. Miller, L. E. Claypool, D. D. Ho, and N. J. Alexander.  1996.  Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Medicine 2:1084-1089.

Haase, A. T., K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z. Zhang, P. J. Dailey, H. H. Balfour, Jr., A. Erice, and A. S. Perelson.  1996.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue. Science 274: 985-989.


Dr. Peter J. Dailey is a microbiologist who serves as a Senior Technical Officer for the Foundation for Innovative Diagnostics (FIND). Dr. Dailey received his PhD in Microbiology and MPH at UC Berkeley and his bachelor’s degree in Bacteriology at UC Davis. He has 35 years of experience in infectious disease, primarily in the research and development of infectious disease molecular diagnostics. He has worked for the California Public Health Department (Viral & Rickettsial Disease Laboratory), hospital and medical center clinical laboratories, and in the molecular diagnostics biotechnology industry. Previously he was the senior vice president of Research & Development at Cepheid, a molecular diagnostics biotechnology company in Sunnyvale, California, and he has also held R&D leadership positions at Roche Molecular Systems and Chiron Diagnostics. He has led the research and development of over 20 diagnostic and blood-screening assays for infectious diseases including TB, MRSA, West Nile Virus, viral meningitis, HPV, HIV, SIV, and HCV.

Other interests: 
  • Member, Committee for Laboratory and Environmental Biosafety (UC Berkeley’s Institutional Biosafety Committee [IBC])
  • Associate Editor, Diagnostic Microbiology and Infectious Diseases
  • Point of Care Diagnostics Idea Lab (
  • UC Berkeley One Health Student Initiative (faculty advisor)
Profile Updated: July 27, 2017